MedTrace Logo

Thalidomide With or Without Probiotics in Radioactive Oral Mucositis

NCT05059613 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-09-28

No results posted yet for this study

Summary

Study on the application of thalidomide with or without probiotics in radioactive oral mucositis

Conditions

  • Oral Mucositis
  • Quality of Life

Interventions

OTHER

probiotics

one times a day during the whole treatment

Sponsors & Collaborators

  • Jiangxi Provincial Cancer Hospital

    lead OTHER

Principal Investigators

  • Chunling Jiang, MD PHD · Jiangxi Provincial Cancer Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-20
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05059613 on ClinicalTrials.gov